Sean Downing

Sean Downing, PhD MBA, currently serves as Vice President of Scientific Affairs at ICON plc since October 2023. With a diverse consulting background since 2017, Sean has provided expertise in biomarker strategies, immuno-oncology, and pathology laboratory workflows for multiple undisclosed companies. Previously, significant roles at Takeda included Senior Director of Bioanalytical & Biomarker Sciences & Technologies and Director of Molecular Pathology. Sean also contributed to Ultivue, Inc. as Senior Director of Biology and Biomarker Programs, and led teams at PerkinElmer, enhancing revenue and expanding personnel. Educational credentials consist of a PhD in Cancer Genetics, an MBA in Information Technology, and a post-doctoral fellowship at Harvard Medical School.